|
1
|
Needleman H and Huff J: The international
agency for research on cancer and obligate transparency. Lancet
Oncol. 6:920–921. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ellis MJ, Ding L, Shen D, Luo J, Suman VJ,
Wallis JW, van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, et al:
Whole-genome analysis informs breast cancer response to aromatase
inhibition. Nature. 486:353–360. 2012.PubMed/NCBI
|
|
3
|
Ruark E, Snape K, Humburg P, Loveday C,
Bajrami I, Brough R, Rodrigues DN, Renwick A, Seal S, Ramsay E, et
al: Mosaic PPM1D mutations are associated with predisposition to
breast and ovarian cancer. Nature. 493:406–410. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stephens PJ, Tarpey PS, Davies H, van Loo
P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell
GR, et al: The landscape of cancer genes and mutational processes
in breast cancer. Nature. 486:400–404. 2012.PubMed/NCBI
|
|
5
|
Li W, Shi Q, Wang W, Liu J, Li Q and Hou
F: Calcium channel blockers and risk of breast cancer: A
meta-analysis of 17 observational studies. PLoS One. 9:e1058012014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li CI, Malone KE, Weiss NS, Boudreau DM,
Cushing-Haugen KL and Daling JR: Relation between use of
antihypertensive medications and risk of breast carcinoma among
women ages 65–79 years. Cancer. 98:1504–1513. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Largent JA, Bernstein L, Horn-Ross PL,
Marshall SF, Neuhausen S, Reynolds P, Ursin G, Zell JA, Ziogas A
and Anton-Culver H: Hypertension, antihypertensive medication use,
and breast cancer risk in the California teachers study cohort.
Cancer Causes Control. 21:1615–1624. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo DQ, Zhang H, Tan SJ and Gu YC:
Nifedipine promotes the proliferation and migration of breast
cancer cells. PLoS One. 9:e1136492014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ahr HJ, Bomhard E, Enzmann H, Karbe E,
Mager H, Sander E and Schlüter G: Calcium channel blockers and the
risk of cancer: A preclinical assessment. Cardiovasc Drugs Ther.
12:157–169. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Braun S, Boyko V, Behar S, Reicher-Reiss
H, Laniado S, Kaplinsky E and Goldbourt U: Calcium channel blocking
agents and risk of cancer in patients with coronary heart disease.
Benzafibrate infarction prevention (BIP) study research group. J Am
Coll Cardiol. 31:804–808. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fryzek JP, Poulsen AH, Lipworth L,
Pedersen L, Nørgaard M, McLaughlin JK and Friis S: A cohort study
of antihypertensive medication use and breast cancer among Danish
women. Breast Cancer Res Treat. 97:231–236. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Coleman CI, Baker WL, Kluger J and White
CM: Antihypertensive medication and their impact on cancer
incidence: A mixed treatment comparison meta-analysis of randomized
controlled trials. J Hypertens. 26:622–629. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alfonzo-Méndez MA, Castillo-Badillo JA,
Romero-Ávila MT, Rivera R, Chun J and García-Sáinz JA: Carboxyl
terminus-truncated alpha1D-adrenoceptors inhibit the ERK pathway.
Naunyn Schmiedebergs Arch Pharmacol. 389:911–920. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Soule HD, Vazguez J, Long A, Albert S and
Brennan M: A human cell line from a pleural effusion derived from a
breast carcinoma. J Natl Cancer Inst. 51:1409–1416. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tabei I, Nishiyama S, Yamashita S,
Hashimoto H, Tachibana T, Uchida K and Ishikawa H: Establishment
and characterization of HER2-positive cell line derived from
pleural effusion of human breast scirrhous carcinoma Hum. Cell.
21:105–112. 2008.
|
|
16
|
Cailleau R, Young R, Olivé M and Reeves WJ
Jr: Breast tumor cell lines from pleural effusions. J Natl Cancer
Inst. 53:661–674. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Gupta A, Wang H, Zhou L,
Vethanayagam RR, Unadkat JD and Mao Q: BCRP transports dipyridamole
and is inhibited by calcium channel blockers. Pharm Res.
22:2023–2034. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Timcheva CV and Todorov DK: Does verapamil
help overcome multidrug resistance in tumor cell lines and cancer
patients? J Chemother. 8:295–299. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Correale P, Tagliaferri P, Celio L, Genua
G, Montagnani S and Bianco AR: Verapamil upregulates sensitivity of
human colon and breast cancer cells to LAK-cytotoxicity in vitro.
Eur J Cancer. 27:1393–1395. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fine RL, Patel J and Chabner BA: Phorbol
esters induce multidrug resistance in human breast cancer cells.
Proc Natl Acad Sci USA. 85:582–586. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garcia-Fernandez MO, Schally AV, Varga JL,
Groot K and Busto R: The expression of growth hormone-releasing
hormone (GHRH) and its receptor splice variants in human breast
cancer lines; the evaluation of signaling mechanisms in the
stimulation of cell proliferation. Breast Cancer Res Treat.
77:15–26. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nie L, Oishi Y, Doi I, Shibata H and
Kojima I: Inhibition of proliferation of MCF-7 breast cancer cells
by a blocker of Ca(2+)-permeable channel. Cell Calcium. 22:75–82.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chung SY, Sung MK, Kim NH, Jang JO, Go EJ
and Lee HJ: Inhibition of P-glycoprotein by natural products in
human breast cancer cells. Arch Pharm Res. 28:823–828. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou XF, Yang X, Wang Q, Coburn RA and
Morris ME: Effects of dihydropyridines and pyridines on multidrug
resistance mediated by breast cancer resistance protein: In vitro
and in vivo studies. Drug Metab Dispos. 33:1220–1228. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roger S, Le Guennec JY and Besson P:
Particular sensitivity to calcium channel blockers of the fast
inward voltage-dependent sodium current involved in the invasive
properties of a metastastic breast cancer cell line. Br J
Pharmacol. 141:610–615. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Loibl S, Bratengeier J, Farines V, von
Minckwitz G, Spänkuch B, Schini-Kerth V, Nepveu F, Strebhardt K and
Kaufmann M: Investigations on the inducible and endothelial nitric
oxide synthases in human breast cancer cell line MCF-7-estrogen has
an influence on e-NOS, but not on i-NOS. Pathol Res Pract. 202:1–7.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng RY, Basudhar D, Ridnour LA, Heinecke
JL, Kesarwala AH, Glynn S, Switzer CH, Ambs S, Miranda KM and Wink
DA: Gene expression profiles of NO- and HNO-donor treated breast
cancer cells: Insights into tumor response and resistance pathways.
Nitric Oxide. 43:17–28. 2014. View Article : Google Scholar : PubMed/NCBI
|
